Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Stroke. 2017 Jan 5;48(2):445–451. doi: 10.1161/STROKEAHA.116.014790

Figure 4.

Figure 4

A, 7 days after warfarin plus 2h MCAO treatment, survival was better in ML351-treated animals, but the difference was not statistically significant (p=0.24; n=7/group). B, Behavioral outcome was significantly improved in the ML351 treatment group (p<0.05 by 2-way ANOVA).